May 2017

New Company!

New Company!

John Nealon and Dr. David Staskin form UroCure and secure intellectual property from Endo/AMS.

Read More
December 2017

Series A Fundraising

Series A Fundraising

UroCure raises $2.8M in Series A funding to finance the development of its first product, the ArcTV Sling System.

January 2019

First Patient Device Card

First Patient Device Card

UroCure announces the ArcTV Patient Device Card, the industry’s first patient device card given to patients after their sling procedure. This provides the patient with the name, sling type, and device lot (tracking) number specific to her sling.

Read More

February 2019

FDA Clearance

FDA Clearance Milestone

UroCure receives FDA 510(k) clearance on its first product, the ArcTV Sling System.

March 2019

Quality & Oversight Committee

Quality Oversight Committee

UroCure establishes the first Quality and Safety Oversight Committee (QSOC) in women’s health, comprised of leading academic experts in urogynecology and female urology.

Read More

April 2019

ACQUIRE Registry

ACQUIRE Registry

UroCure announces partnering sponsorship with the American Urogynecologic Society (AUGS) for their ACQUIRE Registry to track patient outcomes with the ArcTV sling. Through their sponsorship, UroCure demonstrates its support for the society’s efforts to achieve quality patient outcomes and build transparency and trust among physicians, regulatory agencies, and industry.

Read More

July 2019

First Procedure

First Procedure Milestone

Surgeons at Mt. Auburn Hospital—a Harvard Medical School teaching hospital–completes the first ArcTV Sling procedure.

Read More

January 2020

Series B Fundraising

Series B Funding

Company announces completion of Series B funding of $1.8M, including $1M bridge financing.

September 2021

New Partnership with LiNA Medical USA

New Partnership with LiNA Medical USA

UroCure and LiNA Medical announce a sales distribution and product development partnership that leverages the strengths of both companies.

March 2022

Transition to Ongoing Data Collection

Data Collection Milestone

As a result of AUGS’ decision to sunset its ACQUIRE registry, UroCure introduces a proactive text-based reporting system that will provide physicians with a seamless method of sharing feedback about their product experience with the company. UroCure is the first sling company to incorporate a means of gathering information about patient outcomes and post-surgical complications.

July 2022

QR Code Launch

QR Code Launch Milestone

UroCure begins shipping every UroCure sling package with a QR code on the outside label: healthcare providers can scan this code, answer a brief set of questions on their experience with the UroCure sling in the operating room, and send their feedback directly to the company.

September 2022

FDA Clearance

UroCure Slings FDA Clearance

The FDA cleared UroCure’s ArcSP suprapubic and ArcTO transobturator sling systems, building out UroCure’s full range of surgical solutions for stress urinary incontinence.

January 2023

ArcSP Launch

ArcSP Product Image

UroCure and LiNA Medical USA ship the first ArcSP suprapubic slings. The ArcSP is one of two new products approved by the FDA in September of 2022.